Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Inventory Average (2016 - 2025)

Historic Inventory Average for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $2.5 million.

  • Nephros' Inventory Average fell 1570.65% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 1570.65%. This contributed to the annual value of $2.5 million for FY2024, which is 956.78% down from last year.
  • As of Q3 2025, Nephros' Inventory Average stood at $2.5 million, which was down 1570.65% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, Nephros' Inventory Average registered a high of $5.0 million during Q1 2021, and its lowest value of $2.1 million during Q2 2025.
  • For the 5-year period, Nephros' Inventory Average averaged around $3.3 million, with its median value being $2.9 million (2024).
  • As far as peak fluctuations go, Nephros' Inventory Average surged by 6073.1% in 2021, and later plummeted by 5211.39% in 2023.
  • Over the past 5 years, Nephros' Inventory Average (Quarter) stood at $4.6 million in 2021, then decreased by 27.11% to $3.3 million in 2022, then decreased by 28.66% to $2.4 million in 2023, then increased by 20.6% to $2.9 million in 2024, then decreased by 12.93% to $2.5 million in 2025.
  • Its Inventory Average stands at $2.5 million for Q3 2025, versus $2.1 million for Q2 2025 and $2.3 million for Q1 2025.